Back

Challenge 3 - disease modifying treatment for ATTR-CM

11 May 2024 (13:05 - 13:20)
Organised by: Logo
Congress Presentation Part of: Challenges in ATTR Amyloidosis: an expert debate Cardiac Amyloidosis Open Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ahmad Masri

Oregon Health & Science University Medical Group, Portland (United States of America)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor T. Damy (Creteil, FR)
Slides
Presentation thumbnail
Challenge 1 - identifying ATTR in a regular cardiac clinic
Doctor E. Gonzalez Lopez (Madrid, ES)
Slides
Presentation thumbnail
Challenge 2 - managing patients with a mxed phenotype
Doctor J. AGOSTINHO (Lisbon, PT)
Slides
Presentation thumbnail
Closing remarks and Q&A
Professor T. Damy (Creteil, FR)
Slides

Access the full session

Session thumbnail
Challenges in ATTR Amyloidosis: an expert debate
Video

The Event

Event poster

Heart Failure 2024

11 May 2024 13:05 CET
You may be interested in
thumbnail
Congress Session
The bigger picture: an expert assessment on the true impact of ATTR-cardiomyopathy
1 September 2024
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025
thumbnail
Congress Presentation
Impact of disease-modifying treatment on functional capacity in patients with ATTR-CA: pathophysiological insights from iCPET
20 May 2023
thumbnail
Congress Presentation
Amyloid progression or comorbidities? Differentiating management for optimal outcomes
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources